z-logo
Premium
Sanguinarine inhibits VEGF‐induced angiogenesis in a fibrin gel matrix
Author(s) -
Basini Giuseppina,
Bussolati Simona,
Santini Sujen Eleonora,
Grasselli Francesca
Publication year - 2007
Publication title -
biofactors
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.204
H-Index - 94
eISSN - 1872-8081
pISSN - 0951-6433
DOI - 10.1002/biof.5520290102
Subject(s) - angiogenesis , sanguinarine , protein kinase b , phosphorylation , chemistry , pharmacology , endothelial stem cell , mmp2 , vascular endothelial growth factor , cell culture , in vitro , alkaloid , vegf receptors , microbiology and biotechnology , cancer research , biology , biochemistry , downregulation and upregulation , stereochemistry , genetics , gene
Background: The identification of possible ways to block blood vessels formation has become a major scientific objective of the last decade and several phytochemicals are currently being exploited to target tumour angiogenesis. Aim: The effects of Sanguinarine (SA), an alkaloid from the root of Sanguinaria Canadensis, were evaluated in an in vitro angiogenesis model; moreover the effects on Akt phosphorylation in porcine aortic endothelial cell line (AOC) were also examined. Methods: SA (300 nM) was tested in the presence or absence of VEGF (100 ng/ml) in a three dimensional angiogenesis bioassay obtained pipetting a suspension of AOC on microcarrier beads in a fibrinogen solution before the addition of thrombine. Endothelial cell proliferation was measured at 48, 96, 144, 192 h. The phosphorylation of Akt was measured by ELISA in 2×105 AOC treated as described above. Results: The addition of SA abolished ( p < 0.001) VEGF stimulatory effect on AOC growth at all the examined times. In addition, the stimulatory effect induced by VEGF on Akt phosphorylation was significantly ( p < 0.001) inhibited by SA. Conclusion: SA appear to be an antiangiogenic natural product by directly suppressing the proliferative effect of VEGF on endothelial cell line: this effect could be mediated by blocking the VEGF‐induced Akt activation.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom